NO952321L - Polypeptid, samt anti-HIV-preparat fremstilt fra dette - Google Patents

Polypeptid, samt anti-HIV-preparat fremstilt fra dette

Info

Publication number
NO952321L
NO952321L NO952321A NO952321A NO952321L NO 952321 L NO952321 L NO 952321L NO 952321 A NO952321 A NO 952321A NO 952321 A NO952321 A NO 952321A NO 952321 L NO952321 L NO 952321L
Authority
NO
Norway
Prior art keywords
lysine
ornithine
polypeptide
glycyl
prolyl
Prior art date
Application number
NO952321A
Other languages
English (en)
Norwegian (no)
Other versions
NO952321D0 (no
Inventor
Akiyoshi Matsumoto
Michinori Waki
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Publication of NO952321D0 publication Critical patent/NO952321D0/no
Publication of NO952321L publication Critical patent/NO952321L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Length Measuring Devices Characterised By Use Of Acoustic Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO952321A 1993-10-14 1995-06-13 Polypeptid, samt anti-HIV-preparat fremstilt fra dette NO952321L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28034693 1993-10-14
PCT/JP1994/001706 WO1995010534A1 (en) 1993-10-14 1994-10-12 Polypeptide and anti-hiv agent prepared therefrom

Publications (2)

Publication Number Publication Date
NO952321D0 NO952321D0 (no) 1995-06-13
NO952321L true NO952321L (no) 1995-08-09

Family

ID=17623732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952321A NO952321L (no) 1993-10-14 1995-06-13 Polypeptid, samt anti-HIV-preparat fremstilt fra dette

Country Status (17)

Country Link
US (1) US5776899A (de)
EP (1) EP0677061B1 (de)
JP (1) JPH08504837A (de)
KR (1) KR100208873B1 (de)
CN (1) CN1038841C (de)
AT (1) ATE177114T1 (de)
AU (1) AU682405B2 (de)
CA (1) CA2151283A1 (de)
CZ (1) CZ287239B6 (de)
DE (1) DE69416824T2 (de)
FI (1) FI952900A0 (de)
HU (1) HU217442B (de)
NO (1) NO952321L (de)
NZ (1) NZ274560A (de)
RU (1) RU2136696C1 (de)
WO (1) WO1995010534A1 (de)
ZA (1) ZA948005B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
US6653442B1 (en) 1993-07-20 2003-11-25 Intrabiotics Pharmaceuticals, Inc. Protegrins
US5693486A (en) * 1993-07-20 1997-12-02 Intrabiotics DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity
WO1998016555A1 (en) * 1996-10-15 1998-04-23 Seikagaku Corporation Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide
WO1998043995A1 (en) * 1997-03-28 1998-10-08 Seikagaku Corporation Novel anti-hiv complexes and medicinal compositions
KR20020019126A (ko) * 1999-08-09 2002-03-09 트리펩 아베 트리펩티드를 함유하는 약학 조성물
US6337317B1 (en) * 2000-06-27 2002-01-08 The University Of British Columbia Antimicrobial peptides and methods of use thereof
RU2175973C1 (ru) * 2000-08-10 2001-11-20 Гепвитания Лимитед Способ получения тетрадекапептида
US7138488B2 (en) 2000-09-05 2006-11-21 Biokine Therapeutics Ltd. Polypeptides having anti-HIV activity and compositions comprising same
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
WO2003024995A1 (en) * 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
KR100932520B1 (ko) * 2002-10-31 2009-12-17 박래옥 항암제 조성물
JP4781621B2 (ja) * 2002-08-27 2011-09-28 バイオカイン セラピューティックス リミテッド Ｃｘｃｒ４拮抗薬およびその用途
ES2403932T3 (es) 2002-08-27 2013-05-22 Biokine Therapeutics Ltd. Antagonista de CXCR4 y uso del mismo
WO2004039379A1 (en) * 2002-10-31 2004-05-13 Lae-Ok Park Anticancer or antiviral composition
US20040132642A1 (en) * 2002-11-12 2004-07-08 Government Of The U.S.A., Represented By The Secretary, Dept. Of Health & Human Services Methods of inhibiting metastasis or growth of a tumor cell
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
EP1603546A1 (de) * 2003-02-21 2005-12-14 Tripep AB Glycinamid-derivat zur hemmung der hiv-replikation
AU2003232253A1 (en) 2003-05-02 2004-11-23 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
CN104558126B (zh) 2006-03-10 2020-02-14 派特塞尔有限公司 Hiv的调节或辅助蛋白的肽、组合物及它们的应用
CN100366633C (zh) * 2006-04-18 2008-02-06 河北师范大学 棕点湍蛙抗病毒多肽及其在制药中的应用
EP2759302A3 (de) 2006-12-21 2014-11-05 Biokine Therapeutics LTD. 4F-benzoyl-TN14003 kombiniert mit Rituximab für die Verwendung in der Behandlung eines Tumors
US9271933B2 (en) * 2007-11-27 2016-03-01 Rutgers, The State University Of New Jersey Graft copolymer polyelectrolyte complexes for drug delivery
US9789194B2 (en) 2007-11-27 2017-10-17 Rutgers, The State University Of New Jersey Graft copolymer polyelectrolyte complexes for drug delivery
EP3301116A1 (de) 2008-08-25 2018-04-04 Dana Farber Cancer Institute, Inc. Konserviertes influenzahämagglutininepitop und antikörper dagegen
MX2011013459A (es) 2009-06-14 2012-05-08 Biokine Therapeutics Ltd Terapia de peptido para incrementar los niveles de plaquetas.
CN103703018B (zh) 2011-06-07 2016-10-26 波利弗尔股份公司 作为CXC4拮抗剂的β-发夹肽模拟物
EP2841084B1 (de) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs
CN104072579B (zh) * 2014-06-11 2017-01-25 南方医科大学 具有抗菌抗病毒活性的小分子肽及其活性修饰物
EP3322431A2 (de) 2015-07-16 2018-05-23 Biokine Therapeutics Ltd. Zusammensetzungen und verfahren zur behandlung von krebs
KR102033920B1 (ko) 2016-02-23 2019-10-18 바이오라인알엑스 리미티드 급성 골수성 백혈병을 치료하는 방법
RU2658781C1 (ru) * 2017-12-28 2018-06-22 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Пептид, обладающий противоопухолевой активностью
CN110841607B (zh) * 2019-11-22 2020-07-24 中国科学院地质与地球物理研究所 一种超低本底金特效树脂及其制备和应用
CN115490756A (zh) * 2021-06-18 2022-12-20 深圳市健翔生物制药有限公司 一种固液相结合制备依特卡肽的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
JP2641744B2 (ja) * 1988-08-18 1997-08-20 マルハ株式会社 新規ペプチド及び抗菌剤
JP2641742B2 (ja) * 1988-08-18 1997-08-20 マルハ株式会社 新規ペプチド及び抗菌剤
JP2798711B2 (ja) * 1988-09-26 1998-09-17 生化学工業株式会社 ポリペプチド系抗ウィルス剤
DE69115878T2 (de) * 1990-09-11 1996-06-05 Seikagaku Kogyo Co., Ltd., Tokio/Tokyo Neue polypeptide und damit hergestellte anti-hiv medikamente
JP3266311B2 (ja) * 1991-05-02 2002-03-18 生化学工業株式会社 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
OA09696A (en) * 1991-05-02 1993-08-30 Seikagaku Kogyo Co Ltd Novel polypeptides with affinity to lipopolysaccharides and their uses
JP2500194B2 (ja) 1993-08-10 1996-05-29 株式会社ヴァンドームヤマダ 商品発注システム

Also Published As

Publication number Publication date
FI952900A7 (fi) 1995-06-13
HUT72974A (en) 1996-06-28
CZ153395A3 (en) 1995-12-13
WO1995010534A1 (en) 1995-04-20
KR100208873B1 (ko) 1999-07-15
FI952900A0 (fi) 1995-06-13
CN1116427A (zh) 1996-02-07
EP0677061B1 (de) 1999-03-03
AU7862894A (en) 1995-05-04
CZ287239B6 (en) 2000-10-11
CN1038841C (zh) 1998-06-24
DE69416824T2 (de) 1999-07-08
HU9501719D0 (en) 1995-08-28
HU217442B (hu) 2000-01-28
NZ274560A (en) 1998-03-25
EP0677061A1 (de) 1995-10-18
RU95112539A (ru) 1997-06-27
US5776899A (en) 1998-07-07
ZA948005B (en) 1996-02-06
CA2151283A1 (en) 1995-04-20
NO952321D0 (no) 1995-06-13
ATE177114T1 (de) 1999-03-15
DE69416824D1 (de) 1999-04-08
RU2136696C1 (ru) 1999-09-10
JPH08504837A (ja) 1996-05-28
AU682405B2 (en) 1997-10-02

Similar Documents

Publication Publication Date Title
NO952321L (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
DE10075019I2 (de) Neue Proteine mit TNF-Hemmender Wirkung und ihre Herstellung.
AU9174398A (en) Peptides
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
WO2000002916A3 (en) PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY
EP0335483A3 (de) Kondensierte Imidazolderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
Meienhofer et al. Solid-phase synthesis of [8-arginine]-vasopressin through a crystalline protected nonapeptide intermediate and biological properties of the hormone
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
AU1599892A (en) Novel polypeptides with affinity to lipopolysaccharides and their uses
NZ336793A (en) Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
Katsoyannis et al. The synthesis of the histidine analog of the vasopressins
ATE205855T1 (de) Gegen bakterien, mycota und viren wirksame vertebraten proteine und dessen kosmetische zubereitungen
CA2133089A1 (en) Novel cyclic amino acids and derivatives thereof
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
Strachan Total synthesis of an enzyme. II. Synthesis of a protected tetratetracontapeptide corresponding to the 21-64 sequence of ribonuclease A
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DK102792D0 (da) Spergualinderivater, fremgangsmaade til deres fremstilling, farmaceutisk praeparat, hvori de indgaar, og fremgangsmaade til fremstilling af praeparatet
Prasad et al. Structure-activity relationships in luteinizing hormone-releasing hormone
AU585167B2 (en) Novel substrate peptides
EP0249412A3 (en) C-terminal alpha-amidating enzyme and process for production and use thereof
CA2109433A1 (en) Substituted benzhydrylamines as handles for solid phase peptide synthesis
Kamei et al. Amino acid sequence of a lysozyme (B-enzyme) from Bacillus subtilis YT-25
AU6627681A (en) Octapeptide of angiotensin-02 antagonizing effects
Walter et al. Conformational constraints within neurohypophyseal hormones influencing the action of chymotrypsin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application